OPRM1 and inflammatory bowel disease: These findings suggest that, in mice, MOR agonist analgesics worsen the depression of nesting caused by colonic inflammation and provide support to clinical evidence in humans that opioids can reduce the quality of life of IBD patients (17, 23–25).